Although the composition of genetic variants in our MPN–SC patients with or without the JAK2 46/1 haplotype was indistinguishable, we nevertheless identified a trend showing a remarkably higher proportion (76.9%) of MPN–SC patients harboring this haplotype than those without SCs (57.1%). The gene discussed is JAK2; the disease is myeloproliferative neoplasm.